THYMOSIN ALPHA-1

$139.99

Thymosin Alpha-1 (Tα1) is a synthetic peptide modeled after a natural thymic protein, recognized for its role in enhancing immune regulation, T-cell activity, and inflammation control. Extensively studied in research related to immune deficiencies, chronic infections, and recovery from physiological stress, this 10 mg peptide is valued for its potential in supporting immune resilience and restoring immune balance.

Supplied in lyophilized (freeze-dried) white powder form for maximum stability. Best reconstituted with bacteriostatic water, available separately in our reconstitution solutions section.

Description

Thymosin Alpha-1 (Tα1) is a research-grade synthetic peptide designed to replicate the function of a naturally occurring thymic protein involved in immune system regulation and defense. Offered in a 10mg format, this high-purity peptide is ideal for studies focused on T-cell function, immune system resilience, and inflammation modulation.

Tα1 is derived from prothymosin alpha, a thymus-derived precursor protein crucial to immune homeostasis. It has been widely researched for its ability to enhance T-lymphocyte activity, improve cytokine signaling, and support the body’s natural immune response under stressors such as infection, injury, or immunosuppressive conditions.

In laboratory settings, Thymosin Alpha-1 has shown potential in studies involving chronic viral infections, immune suppression, and recovery following chemotherapy or surgery. Researchers have also investigated its ability to stimulate natural killer (NK) cells, influence antigen presentation, and help rebalance Th1/Th2 immune pathways—critical mechanisms in immune dysfunction, inflammation control, and immunotherapy development.

This peptide provides a robust platform for advanced immune system research, offering valuable insight into restoring immunological balance and enhancing innate immune responses.

Reviews

There are no reviews yet.

Be the first to review “THYMOSIN ALPHA-1”

Your email address will not be published. Required fields are marked *